When Less is More: The Rising Tide of Hypofractionation

This publication has 21 references indexed in Scilit:

• The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer
  Clinical Oncology, 2022
• Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy10
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
• Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II)
  JAMA Oncology, 2021
• High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2021
• The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
  The Lancet Oncology, 2021
• Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
• Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
  Radiotherapy and Oncology, 2020
• Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
  The Lancet Oncology, 2016
• Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
• Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
  Radiotherapy and Oncology, 2005